You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

COVID-19 Impact on Global Chorea Treatment Market Size, Status and Forecast 2020-2026

Chorea is an abnormal involuntary movement characterized by brief, abrupt, unpredictable, irregular, non-stereotyped movements. Chorea may worsen with anxiety and voluntary movements, and subsides during sleep The major causes of chorea include use of oral contraceptives, pregnancy, autoimmune disorders, paraneoplastic syndromes, hyperthyroidism, hypoparathyroidism, and hyperglycemia.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Chorea Treatment market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Chorea Treatment industry.
Based on our recent survey, we have several different scenarios about the Chorea Treatment YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Chorea Treatment will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chorea Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chorea Treatment market in terms of revenue.
Players, stakeholders, and other participants in the global Chorea Treatment market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Chorea Treatment market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Chorea Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chorea Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chorea Treatment market.
The following players are covered in this report:
Medtronic
Boston Scientific
Aleva Neurotherapeutics
Teva Pharmaceutical
Pfizer
GlaxoSmithKline
Bausch Health Companies
LivaNova
Lundbeck
Ipsen
Alnylam Pharmaceuticals
Prana Biotechnology
RespireRx Pharmaceuticals
Vertex Pharmaceuticals
SOM Biotech
Chorea Treatment Breakdown Data by Type
Medication
Surgery Therapy
Chorea Treatment Breakdown Data by Application
Hospitals
Clinics
Others
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Chorea Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Chorea Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Medication
1.4.3 Surgery Therapy
1.5 Market by Application
1.5.1 Global Chorea Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Chorea Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Chorea Treatment Industry
1.6.1.1 Chorea Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Chorea Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Chorea Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Global Growth Trends by Regions
2.1 Chorea Treatment Market Perspective (2015-2026)
2.2 Chorea Treatment Growth Trends by Regions
2.2.1 Chorea Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Chorea Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Chorea Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Chorea Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Chorea Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Chorea Treatment Players by Market Size
3.1.1 Global Top Chorea Treatment Players by Revenue (2015-2020)
3.1.2 Global Chorea Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Chorea Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Chorea Treatment Market Concentration Ratio
3.2.1 Global Chorea Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Chorea Treatment Revenue in 2019
3.3 Chorea Treatment Key Players Head office and Area Served
3.4 Key Players Chorea Treatment Product Solution and Service
3.5 Date of Enter into Chorea Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Chorea Treatment Historic Market Size by Type (2015-2020)
4.2 Global Chorea Treatment Forecasted Market Size by Type (2021-2026)

5 Chorea Treatment Breakdown Data by Application (2015-2026)
5.1 Global Chorea Treatment Market Size by Application (2015-2020)
5.2 Global Chorea Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Chorea Treatment Market Size (2015-2020)
6.2 Chorea Treatment Key Players in North America (2019-2020)
6.3 North America Chorea Treatment Market Size by Type (2015-2020)
6.4 North America Chorea Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Chorea Treatment Market Size (2015-2020)
7.2 Chorea Treatment Key Players in Europe (2019-2020)
7.3 Europe Chorea Treatment Market Size by Type (2015-2020)
7.4 Europe Chorea Treatment Market Size by Application (2015-2020)

8 China
8.1 China Chorea Treatment Market Size (2015-2020)
8.2 Chorea Treatment Key Players in China (2019-2020)
8.3 China Chorea Treatment Market Size by Type (2015-2020)
8.4 China Chorea Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Chorea Treatment Market Size (2015-2020)
9.2 Chorea Treatment Key Players in Japan (2019-2020)
9.3 Japan Chorea Treatment Market Size by Type (2015-2020)
9.4 Japan Chorea Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Chorea Treatment Market Size (2015-2020)
10.2 Chorea Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Chorea Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Chorea Treatment Market Size by Application (2015-2020)

11 India
11.1 India Chorea Treatment Market Size (2015-2020)
11.2 Chorea Treatment Key Players in India (2019-2020)
11.3 India Chorea Treatment Market Size by Type (2015-2020)
11.4 India Chorea Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Chorea Treatment Market Size (2015-2020)
12.2 Chorea Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Chorea Treatment Market Size by Type (2015-2020)
12.4 Central & South America Chorea Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Medtronic
13.1.1 Medtronic Company Details
13.1.2 Medtronic Business Overview and Its Total Revenue
13.1.3 Medtronic Chorea Treatment Introduction
13.1.4 Medtronic Revenue in Chorea Treatment Business (2015-2020))
13.1.5 Medtronic Recent Development
13.2 Boston Scientific
13.2.1 Boston Scientific Company Details
13.2.2 Boston Scientific Business Overview and Its Total Revenue
13.2.3 Boston Scientific Chorea Treatment Introduction
13.2.4 Boston Scientific Revenue in Chorea Treatment Business (2015-2020)
13.2.5 Boston Scientific Recent Development
13.3 Aleva Neurotherapeutics
13.3.1 Aleva Neurotherapeutics Company Details
13.3.2 Aleva Neurotherapeutics Business Overview and Its Total Revenue
13.3.3 Aleva Neurotherapeutics Chorea Treatment Introduction
13.3.4 Aleva Neurotherapeutics Revenue in Chorea Treatment Business (2015-2020)
13.3.5 Aleva Neurotherapeutics Recent Development
13.4 Teva Pharmaceutical
13.4.1 Teva Pharmaceutical Company Details
13.4.2 Teva Pharmaceutical Business Overview and Its Total Revenue
13.4.3 Teva Pharmaceutical Chorea Treatment Introduction
13.4.4 Teva Pharmaceutical Revenue in Chorea Treatment Business (2015-2020)
13.4.5 Teva Pharmaceutical Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview and Its Total Revenue
13.5.3 Pfizer Chorea Treatment Introduction
13.5.4 Pfizer Revenue in Chorea Treatment Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 GlaxoSmithKline
13.6.1 GlaxoSmithKline Company Details
13.6.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.6.3 GlaxoSmithKline Chorea Treatment Introduction
13.6.4 GlaxoSmithKline Revenue in Chorea Treatment Business (2015-2020)
13.6.5 GlaxoSmithKline Recent Development
13.7 Bausch Health Companies
13.7.1 Bausch Health Companies Company Details
13.7.2 Bausch Health Companies Business Overview and Its Total Revenue
13.7.3 Bausch Health Companies Chorea Treatment Introduction
13.7.4 Bausch Health Companies Revenue in Chorea Treatment Business (2015-2020)
13.7.5 Bausch Health Companies Recent Development
13.8 LivaNova
13.8.1 LivaNova Company Details
13.8.2 LivaNova Business Overview and Its Total Revenue
13.8.3 LivaNova Chorea Treatment Introduction
13.8.4 LivaNova Revenue in Chorea Treatment Business (2015-2020)
13.8.5 LivaNova Recent Development
13.9 Lundbeck
13.9.1 Lundbeck Company Details
13.9.2 Lundbeck Business Overview and Its Total Revenue
13.9.3 Lundbeck Chorea Treatment Introduction
13.9.4 Lundbeck Revenue in Chorea Treatment Business (2015-2020)
13.9.5 Lundbeck Recent Development
13.10 Ipsen
13.10.1 Ipsen Company Details
13.10.2 Ipsen Business Overview and Its Total Revenue
13.10.3 Ipsen Chorea Treatment Introduction
13.10.4 Ipsen Revenue in Chorea Treatment Business (2015-2020)
13.10.5 Ipsen Recent Development
13.11 Alnylam Pharmaceuticals
10.11.1 Alnylam Pharmaceuticals Company Details
10.11.2 Alnylam Pharmaceuticals Business Overview and Its Total Revenue
10.11.3 Alnylam Pharmaceuticals Chorea Treatment Introduction
10.11.4 Alnylam Pharmaceuticals Revenue in Chorea Treatment Business (2015-2020)
10.11.5 Alnylam Pharmaceuticals Recent Development
13.12 Prana Biotechnology
10.12.1 Prana Biotechnology Company Details
10.12.2 Prana Biotechnology Business Overview and Its Total Revenue
10.12.3 Prana Biotechnology Chorea Treatment Introduction
10.12.4 Prana Biotechnology Revenue in Chorea Treatment Business (2015-2020)
10.12.5 Prana Biotechnology Recent Development
13.13 RespireRx Pharmaceuticals
10.13.1 RespireRx Pharmaceuticals Company Details
10.13.2 RespireRx Pharmaceuticals Business Overview and Its Total Revenue
10.13.3 RespireRx Pharmaceuticals Chorea Treatment Introduction
10.13.4 RespireRx Pharmaceuticals Revenue in Chorea Treatment Business (2015-2020)
10.13.5 RespireRx Pharmaceuticals Recent Development
13.14 Vertex Pharmaceuticals
10.14.1 Vertex Pharmaceuticals Company Details
10.14.2 Vertex Pharmaceuticals Business Overview and Its Total Revenue
10.14.3 Vertex Pharmaceuticals Chorea Treatment Introduction
10.14.4 Vertex Pharmaceuticals Revenue in Chorea Treatment Business (2015-2020)
10.14.5 Vertex Pharmaceuticals Recent Development
13.15 SOM Biotech
10.15.1 SOM Biotech Company Details
10.15.2 SOM Biotech Business Overview and Its Total Revenue
10.15.3 SOM Biotech Chorea Treatment Introduction
10.15.4 SOM Biotech Revenue in Chorea Treatment Business (2015-2020)
10.15.5 SOM Biotech Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
  • FORMAT: PDF
  • PUBLISHED DATE: Jun, 2020
  • NO OF PAGES: 125